Immunotherapy Bacterial vaginosis and Trichomoniasis

Clinical efficiency of a vaccine Solco Trichovac was investigated at treatment Bacterial vaginosis (18) and Trichomoniasis (12) in comparison with traditional application Metronidazol (accordingly two groups of matching on 20 patients). In an extremity of course of treatment Solco Trichovac clinical and laboratory the confirmed recovery is marked at 86,7 % ill, the positive proof effect was saved at 75 % in separated period. In groups of matching - is similar at 67,5 % and at 55 %. The treatment Bacterial vaginosis and Trichomoniasis by immunisation has advantages before system application antibacterial’s of tools and highly effectively in complex treatment of infections vagina.